Silsesquioxane-Based and Hydroxyapatite-Containing Hybrid Biomaterials for Bone Regeneration: Evidence, Limitations, and Future Directions
Open Access
- 28 September 2026
- journal article
- review article
- Published by MDPI AG in Encyclopedia
- Vol. 6 (10) , 211
Abstract
The repair of critical bone defects remains a substantial clinical challenge. A regenerative material must support osteogenesis, provide appropriate mechanical function, and degrade at a rate compatible with tissue formation. Hydroxyapatite (HA) is osteoconductive and chemically similar to bone mineral, but its brittleness and slow resorption limit its use as a stand-alone load-bearing material. Silsesquioxanes, particularly polyhedral oligomeric silsesquioxanes (POSS), provide molecularly defined silicon–oxygen frameworks with modifiable organic substituents. These can be incorporated as fillers or covalent network components. This review critically evaluates silsesquioxane-based biomaterials for bone regeneration. It distinguishes direct evidence from HA-containing systems from mechanistic analogues. These analogues include silicate-substituted HA, bioactive glass, dental POSS composites, and related polymer–POSS materials. Sol–gel processing, in situ mineralisation, particle incorporation, surface grafting, and network formation are assessed in relation to interfacial bonding, apatite nucleation, mechanical behaviour, and degradation. Current evidence indicates that reinforcement depends on cage functionality, dispersion, loading, matrix chemistry, and interfacial integration. Direct evidence that implanted HA–POSS systems release orthosilicic acid at biologically active concentrations remains unavailable. Cross-system comparisons further show that reported mechanical values cannot be ranked without accounting for physical form, porosity, test mode, and environmental conditions. The principal translational barriers are (i) the scarcity of load-bearing in vivo studies, (ii) uncertain degradation-product fate, and (iii) sterilisation sensitivity in some POSS-modified polymers. Further barriers are (iv) limited manufacturing standardisation and (v) the absence of clinically validated HA–POSS implants. The most defensible rationale for these hybrids is therefore their capacity for multifunctional interfacial design rather than universal mechanical superiority.Keywords
Funding Information
- Walailak University (WU68206)
- Walailak University (WU-CIA-03504/2025)
This publication has 120 references indexed in Scilit:
- Inhibitory effects of orthosilicic acid on osteoclastogenesis in RANKL‐stimulated RAW264.7 cellsJournal of Biomedical Materials Research Part A, 2021
- Large Polyhedral Oligomeric Silsesquioxane Cages: The Isolation of Functionalized POSS with an Unprecedented Si18O27 CoreAngewandte Chemie International Edition, 2020
- Incorporating silica‐coated graphene in bioceramic nanocomposites to simultaneously enhance mechanical and biological performanceJournal of Biomedical Materials Research Part A, 2020
- Janus‐Cube Octasilsesquioxane: Facile Synthesis and Structure ElucidationAngewandte Chemie International Edition, 2016
- Bone as a Structural MaterialAdvanced Healthcare Materials, 2015
- Development of resorbable nanocomposite tracheal and bronchial scaffolds for paediatric applicationsBritish Journal of Surgery, 2015
- Silica‐Gelatin Hybrids with Tailorable Degradation and Mechanical Properties for Tissue RegenerationAdvanced Functional Materials, 2010
- Degradation studies on biodegradable nanocomposite based on polycaprolactone/polycarbonate (80:20%) polyhedral oligomeric silsesquioxaneJournal of Biomedical Materials Research Part A, 2008
- Ultrastructural comparison of dissolution and apatite precipitation on hydroxyapatite and silicon‐substituted hydroxyapatite in vitro and in vivoJournal of Biomedical Materials Research Part A, 2004
- Collagen–hydroxyapatite composite prepared by biomimetic processJournal of Biomedical Materials Research Part A, 2003